Optovue

Optovue Corporation is an ophthalmic device company dedicated to collaborating with eye care professionals and clinical researchers to lead the commercialization of novel imaging modalities, improving the diagnosis and treatment of ophthalmic diseases. Founded in December 2003 by pioneers in optics coherence tomography, Optovue develops next-generation ophthalmic diagnostic instruments based on Fourier-domain OCT technology. The ultra-high-speed, high-resolution FD-OCT provides physicians with advanced retinal diagnostic capabilities, offering significant benefits for patients with retinal diseases such as macular degeneration, diabetic retinopathy, glaucoma, and other macular conditions.